skip to content »

Dan L. Duncan Cancer Center

Houston, Texas

BCM has 25 departments and more than 90 research and patient-care centers.
Dan L. Duncan Cancer Center
not shown on screen

Director, Experimental Therapeutics Program

The NCI-designated Dan L. Duncan Cancer Center and the Division of Hematology/ Medical Oncology in the Department of Medicine at Baylor College of Medicine announce a search for director of a new program in Experimental Therapeutics. Baylor College of Medicine is a top ten medical school with outstanding clinical and basic research programs. The College is affiliated with five teaching hospitals in the Texas Medical Center providing a large and diverse cancer patient population. The Cancer Center is interested in developing a new research program in experimental therapeutics including phase 1/2 drug development. Candidates should have leadership experience and accomplishments in clinical, translational or basic research in experimental therapeutics or drug development.

The Program in Adult Experimental Therapeutics will complement an already strong Experimental Therapeutics section in the Pediatric Oncology Program of the Cancer Center located in Texas Children’s Hospital. A distinguished candidate will be considered for a professorship or endowed chair. The Cancer Center includes eight outstanding integrated Research Programs in Breast Cancer, Prostate Cancer, Cell and Gene Therapy, Nuclear Receptors, Pediatric Cancer, Prevention and Population Science, Cancer Biology, and Molecular Carcinogenesis. Nine Shared Resources are available to Cancer Center members. The Human Genome Sequencing Center (one of three in the country), an RNAi High Throughput Screening Core Facility, and a Chemical Genomics Screening Core Facility are unique additional resources. A strong Cancer Pharmacology Core Facility is also available.

The 280 members of the Cancer Center bring in more than $100M annually in cancer-related research funding including three SPORE grants in Breast, Prostate, and Lymphoma. The center is the recipient of a $100M naming gift from the Duncan family. The college is building a new hospital and outpatient complex in the Texas Medical Center.

Interested candidates will have an M.D. or M.D./Ph.D. degree and should be board certified in hematology and/or oncology. Applications should include a letter outlining the candidate’s research interests in addition to a curriculum vitae and the names of four references. Baylor College of Medicine is an Equal Opportunity/Affirmative Action/Equal Access Employer.

Please send application to:

C. Kent Osborne, M.D.
Director, Dan L. Duncan Cancer Center
Interim Director, Division of Hematology/Medical Oncology
Baylor College of Medicine
One Baylor Plaza, BCM 600
Houston, Texas 77030
kosborne@bcm.edu
713-798-1641

E-mail this page to a friend